Cell therapy is an innovative approach that offers a potential long-term solution, addressing migraines at their source and ...

AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention ... as Scotland gave a green light to the drug in this indication last October ...